HIV NEWS, CONFERENCES AND EVENTS
Our Media centre contains a range of resources including our latest and archived press releases and news updates, conferences and events we attend, our image and video library and social media information.
These press releases and news updates are intended for media and investors only
LATEST PRESS RELEASES
LATEST NEWS UPDATES
CONFERENCES AND EVENTS
16-19 October
ViiV Healthcare will join a community of infectious disease professionals at IDWeek 2024 in Los-Angeles, California, presenting new data from across our innovative portfolio of medicines.
22-26 July 2024
25th international AIDS conference in Munich will host up to 15,000 people to discuss the latest advancements in HIV research.
4-9 December 2023
The ICASA conference provides a strong platform for leaders, scientists, activists and community in Africa to come together to advance the HIV response. ViiV Healthcare is proud to be at this event: learn more about our presence at ICASA 2023.
Media contacts
Media contact details for our global headquarters and USA. For press contacts in our local operating companies please visit our country websites.
In you have a media query please use our Contact our team form here.
Global Press Office
Rachel Jaikaran
Head of Global Communications ViiV Healthcare
Tel: +44 7823 523 755
US Press Office
Audrey Abernathy
Head of ViiV US External Affairs & Communications
Tel: +1 919 605 4521
NP-GBL-HVX-COCO-220039 | October 2024
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.
